IDR 59.0
(-1.67%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 819.94 Billion | 603.66 Billion | 168.88 Billion | 57.08 Billion |
Cost of Revenue | 788.53 Billion | 579.54 Billion | 162.4 Billion | 55.01 Billion |
Gross Profit | 31.4 Billion | 24.12 Billion | 6.47 Billion | 2.06 Billion |
Operating Expenses | 7.22 Billion | 5.59 Billion | 1.84 Billion | 1.45 Billion |
Selling, General and Administrative Expenses | 6.14 Billion | 4.66 Billion | 1.15 Billion | 936.43 Million |
Research and Development Expenses | - | - | - | - |
Other Expenses | 1.07 Billion | - | - | - |
Cost and Expenses | 795.76 Billion | 585.13 Billion | 164.24 Billion | 56.47 Billion |
Operating Income | 24.18 Billion | 18.48 Billion | 4.58 Billion | 599.3 Million |
Interest Expense | - | - | - | - |
Income Tax Expense | 5.32 Billion | 4.04 Billion | 980.79 Million | 3.35 Million |
Earnings before Tax | 23.92 Billion | 18.38 Billion | 4.5 Billion | 579.08 Million |
Net Income | 18.6 Billion | 14.34 Billion | 3.52 Billion | 582.44 Million |
Earnings Per Share Basic | 13.34 | 18.99 | 4.67 | 0.77 |
Earnings Per Share Diluted | 13.34 | 18.99 | 4.67 | 0.77 |
Weighted Average Shares Outstanding | 1.39 Billion | 755 Million | 755 Million | 755 Million |
Weighted Average Shares Outstanding (Diluted) | 1.39 Billion | 755 Million | 755 Million | 755 Million |
Gross Margin | 0.04 | 0.04 | 0.04 | 0.04 |
EBIT Margin | 0.03 | 0.03 | 0.03 | 0.01 |
Profit Margin | 0.02 | 0.02 | 0.02 | 0.01 |
EBITDA | 25.04 Billion | 19.18 Billion | 4.77 Billion | 699.43 Million |
Earnings Before Tax Margin | 0.03 | 0.03 | 0.03 | 0.01 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | 378.69 Billion | 241.9 Billion | 819.94 Billion | 223.06 Billion | 184.62 Billion | 603.66 Billion |
Cost of Revenue | 368.36 Billion | 232.1 Billion | 788.53 Billion | 214.36 Billion | 177.65 Billion | 579.54 Billion |
Gross Profit | 10.32 Billion | 9.8 Billion | 31.4 Billion | 8.69 Billion | 6.97 Billion | 24.12 Billion |
Operating Expenses | 4.38 Billion | 4.32 Billion | 7.21 Billion | 1.62 Billion | 1.58 Billion | 5.59 Billion |
Selling, General and Administrative Expenses | 3.22 Billion | 3.14 Billion | - | 1.37 Billion | 1.36 Billion | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 1.15 Billion | - | - | - | - | - |
Cost and Expenses | 372.75 Billion | 236.42 Billion | 795.74 Billion | 215.99 Billion | 179.24 Billion | 585.13 Billion |
Operating Income | 5.94 Billion | 5.53 Billion | 24.18 Billion | 7.09 Billion | 5.4 Billion | 18.48 Billion |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 1.3 Billion | 6.37 Million | 5.32 Billion | 1.55 Billion | 1.18 Billion | 4.04 Billion |
Earnings before Tax | 5.85 Billion | 5.43 Billion | 23.92 Billion | 7.03 Billion | 5.34 Billion | 18.38 Billion |
Net Income | 4.54 Billion | 5.42 Billion | 18.6 Billion | 5.47 Billion | 4.16 Billion | 14.34 Billion |
Earnings Per Share Basic | 2.91 | 4.07 | - | 6.55 | 5.52 | - |
Earnings Per Share Diluted | 2.91 | 4.07 | - | 6.55 | 5.52 | - |
Weighted Average Shares Outstanding | 1.56 Billion | 1.33 Billion | 1.39 Billion | 835.73 Million | 755 Million | 755 Million |
Weighted Average Shares Outstanding (Diluted) | 1.56 Billion | 1.33 Billion | 1.39 Billion | 835.73 Million | 755 Million | 755 Million |
Gross Margin | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
EBIT Margin | 0.02 | 0.03 | - | 0.03 | 0.03 | - |
Profit Margin | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
EBITDA | 6.52 Billion | 6.18 Billion | - | 7.15 Billion | 5.46 Billion | - |
Earnings Before Tax Margin | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 |
XENE
ADVANC
BH-R
5515
300936
BIZOTIC